Gerard E. Riedel
Nessuna posizione attualmente
Profilo
Gerard E.
Riedel held former positions as SVP-Regulatory Affairs & Quality Assurance at Praecis Pharmaceuticals, Inc., Vice President-Regulatory Affairs at Momenta Pharmaceuticals, Inc., VP-Regulatory Affairs & Program Management at NormOxys, Inc., and Vice President-Regulatory Affairs at EyePoint Pharmaceuticals, Inc. He obtained a doctorate degree from Harvard University and an undergraduate degree from Harvard College.
Precedenti posizioni note di Gerard E. Riedel
Società | Posizione | Fine |
---|---|---|
EYEPOINT PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Praecis Pharmaceuticals, Inc.
Praecis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Praecis Pharmaceuticals, Inc. develops drugs and therapies for the treatment of cancer. The firm also develops peptide-based drugs. The company was founded 1993 and is headquartered in Waltham, MA. | Consigliere Generale | - |
NormOxys, Inc.
NormOxys, Inc. Pharmaceuticals: MajorHealth Technology NormOxys, Inc. develops small-molecule therapeutics for the treatment of cancer. Its major product is OXY111A. The company was founded by Conrad J Bletzer, Jr. Claude Nicoalu, Jean-Mearie Lehn, Gay Goodman, Ruth Greferath and Roscoe Brady in 2004 and is headquartered in Brighton, MA. | Consigliere Generale | - |
MOMENTA PHARMACEUTICALS, INC. | Consigliere Generale | - |
Formazione di Gerard E. Riedel
Harvard University | Doctorate Degree |
Harvard College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
EYEPOINT PHARMACEUTICALS, INC. | Health Technology |
Aziende private | 3 |
---|---|
Momenta Pharmaceuticals, Inc.
Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
Praecis Pharmaceuticals, Inc.
Praecis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Praecis Pharmaceuticals, Inc. develops drugs and therapies for the treatment of cancer. The firm also develops peptide-based drugs. The company was founded 1993 and is headquartered in Waltham, MA. | Health Technology |
NormOxys, Inc.
NormOxys, Inc. Pharmaceuticals: MajorHealth Technology NormOxys, Inc. develops small-molecule therapeutics for the treatment of cancer. Its major product is OXY111A. The company was founded by Conrad J Bletzer, Jr. Claude Nicoalu, Jean-Mearie Lehn, Gay Goodman, Ruth Greferath and Roscoe Brady in 2004 and is headquartered in Brighton, MA. | Health Technology |
- Borsa valori
- Insiders
- Gerard E. Riedel